BHVN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biohaven Ltd (BHVN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts such as insider buying and hedge fund interest, the stock's technical indicators are bearish, and the company's financial performance is weak with significant losses. The lack of strong trading signals and the absence of immediate catalysts further suggest holding off on investing in this stock right now.
The technical indicators for BHVN are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 40.699, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 9.23, with key support at 8.431 and resistance at 10.028.
Insider buying has increased by 3226.99% over the last month.
Hedge funds are neutral, but Sarissa Capital Management and DAFNA Capital Management have recently acquired significant stakes in the company, indicating confidence in its future potential.
Analysts from TD Cowen, Goldman Sachs, and Raymond James maintain a Buy or Strong Buy rating with optimistic price targets ranging from $22 to $30.
The company's financial performance in Q4 2025 was weak, with net income dropping by -22.10% YoY and EPS declining by -34.59% YoY.
Technical indicators are bearish, and the stock lacks upward momentum.
No recent congress trading data or significant event-driven catalysts in the near term.
In Q4 2025, Biohaven reported no revenue growth, a net income loss of -$145.56 million (down -22.10% YoY), and a significant drop in EPS (-34.59% YoY). The gross margin remained at 0%. These figures indicate poor financial health.
Analysts are generally optimistic about Biohaven's long-term potential, with recent upgrades and increased price targets from firms like TD Cowen ($30), Goldman Sachs ($27), and Raymond James (Strong Buy). However, some analysts, like H.C. Wainwright and BofA, remain cautious due to near-term cash burn and lack of immediate catalysts.
